Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-055269
Filing Date
2009-03-16
Accepted
2009-03-16 15:06:47
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1009270
2 FORM OF SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT dex1031.htm EX-10.31 82084
3 2009 CORPORATE BONUS PLAN dex1032.htm EX-10.32 40777
4 REPORT AND CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1609
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A - 14(A) AND 15D-14 dex311.htm EX-31.1 9239
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A - 14(A) AND 15D-14 dex312.htm EX-31.2 9403
7 CERTIFICATION OF CEO AND CFO PURSUANT TO 18.U.S.C. SECTION 1350 dex321.htm EX-32.1 5930
8 GRAPHIC g23470g11t82.jpg GRAPHIC 25918
9 GRAPHIC g23470g75z33.jpg GRAPHIC 59476
  Complete submission text file 0001193125-09-055269.txt   1277671
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33103 | Film No.: 09683956
SIC: 2834 Pharmaceutical Preparations